Characteristics of included studies
| Study | Year | Patients, n BVS/DES | Study type | Single/multicentre | Clinical presentation | Follow-up, months |
|---|---|---|---|---|---|---|
| ABSORB II | 2016 | 335/166 | Randomised | Multicentre | SA or UA, silent ischaemia, recent MI | 24 |
| ABSORB Japan | 2015 | 266/134 | Randomised | Multicentre | SA or UA | 24 |
| Imori et al | 2016 | 303/748 | Observational, propensity matched | Multicentre | Acute coronary syndrome | 24 |
| BVS examination | 2015 | 290/290 | Observational, propensity matched | Multicentre | STEMI | 24 |
| Absorb China | 2015 | 238/237 | Randomised | Multicentre | SA or UA | 24 |
BVS, bioresorbable vascular scaffold; DES, drug-eluting stents; MI, myocardial infarction; SA, stable angina; STEMI, ST-segment elevation myocardial infarction; UA, unstable angina.